@ObjectiveAcuity is delighted to announce our partnership with @REGENXBIO, using our test to objectively measure visual acuity in studies of children with CLN-2 Batten disease.
https://t.co/l78gjrHlt1
It was super exciting last week to showcase the @ObjectiveAcuity 5G solution, as part of the @SparkNZ 5G Starter Fund Showcase. We have made our fast and easy to use objective vision tests, even faster using 5G.
Objective Acuity is delighted to partner with The Retina Foundation of the Southwest, Dallas, Texas, to undertake a clinical study for our vision screening test in young children.
https://t.co/IuBjx3zGi7